Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03918486 · ClinicalTrials.gov registry record
Caretaker vs. Routine Blood Pressure Sphygmomanometer
A clinical trial of Blood Pressure, sponsored by The Cooper Health System.
- Completed
- Registry status
- 170
- Enrollment target
- 1
- Study location
NCT03918486: Completed study of Blood Pressure, sponsored by The Cooper Health System.
NCT03918486 is a study of Blood Pressure that has completed, run by The Cooper Health System. The registered enrollment target is 170 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03918486, a study of Blood Pressure, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
Caretaker vs. routine blood pressure sphygmomanometer
Primary Outcome
As per blood pressure monitor validation guidelines, the primary outcome measure will be the average difference in systolic and diastolic blood pressure measurements between the investigational device (Caretaker) and the reference (brachial cuff). In line with the ANSI/ISO/AAMI guidelines, we will obtain multiple investigational-reference measurement pairs in each subject (every 5 minutes during the surgical case) and will average the difference over all pairs from all subjects.
Conditions Studied
Interventions
- DEVICE Caretaker
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2017-09-05 |
| Est. Completion | 2021-11-10 |
What the finished NCT03918486 record still lists
NCT03918486 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Caretaker is the first listed.
NCT03918486 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03918486 about?
NCT03918486 is a clinical study titled "Caretaker vs. Routine Blood Pressure Sphygmomanometer". Caretaker vs. routine blood pressure sphygmomanometer
What is the current status of trial NCT03918486?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2017-09-05. Estimated completion is 2021-11-10.
What conditions does trial NCT03918486 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT03918486?
The interventions under investigation include: Caretaker (DEVICE).
Who is sponsoring clinical trial NCT03918486?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03918486 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03918486's enrollment target sits among peer trials
170 22nd of 101 higher than 79 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements
RECRUITING
-
The GUARDIAN Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI